Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Cousins E, Nicholas J.

Recent Results Cancer Res. 2014;193:227-68. doi: 10.1007/978-3-642-38965-8_13. Review.

2.

Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia.

Nicholas J.

Front Biosci. 2007 Jan 1;12:265-81. Review.

PMID:
17127298
3.
4.

The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.

Bussey KA, Reimer E, Todt H, Denker B, Gallo A, Konrad A, Ottinger M, Adler H, Stürzl M, Brune W, Brinkmann MM.

J Virol. 2014 Aug;88(16):9245-59. doi: 10.1128/JVI.00841-14. Epub 2014 Jun 4.

5.
6.

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E.

Clin Microbiol Rev. 2002 Jul;15(3):439-64. Review.

7.

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Epub 2013 Apr 6. Review.

PMID:
23567332
8.

Human herpesvirus-8-encoded signalling ligands and receptors.

Nicholas J.

J Biomed Sci. 2003 Sep-Oct;10(5):475-89. Review.

PMID:
12928588
9.

Kaposi's sarcoma and other manifestations of human herpesvirus 8.

Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring SK.

J Am Acad Dermatol. 2002 Nov;47(5):641-55; quiz 656-8. Review.

PMID:
12399755
12.

Activation of human herpesvirus replication by apoptosis.

Prasad A, Remick J, Zeichner SL.

J Virol. 2013 Oct;87(19):10641-50. doi: 10.1128/JVI.01178-13. Epub 2013 Jul 24. Erratum in: J Virol. 2016 Jul 1;90(13):6171-2.

13.

The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.

Jäger W, Santag S, Weidner-Glunde M, Gellermann E, Kati S, Pietrek M, Viejo-Borbolla A, Schulz TF.

J Virol. 2012 Jun;86(12):6745-57. doi: 10.1128/JVI.06840-11. Epub 2012 Apr 18.

14.

Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.

Lu C, Zeng Y, Huang Z, Huang L, Qian C, Tang G, Qin D.

Am J Pathol. 2005 Jan;166(1):173-83.

15.

Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.

Kalt I, Masa SR, Sarid R.

Methods Mol Biol. 2009;471:387-407. doi: 10.1007/978-1-59745-416-2_19.

PMID:
19109790
17.

Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.

Staudt MR, Dittmer DP.

Curr Drug Targets Infect Disord. 2003 Jun;3(2):129-35. Review.

PMID:
12769790
18.

Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies.

Malnati MS, Dagna L, Ponzoni M, Lusso P.

Rev Clin Exp Hematol. 2003 Dec;7(4):375-405. Review.

PMID:
15129649
19.
20.

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.

Schulz TF.

J Antimicrob Chemother. 2000 Apr;45 Suppl T3:15-27. Review.

PMID:
10855768

Supplemental Content

Support Center